RETA
Reata Pharmaceuticals Inc
SVP, Global Regulatory Affairs Andrea Loewen sold $1.6M of Reata Pharmaceuticals Inc
Sold$1,588,137
$83.43Price
19,036Shares
−33%Stake
What RETA did after the filing
- The stock from Thu, Mar 9 close, $84.60
- +18.2%
- S&P 500, same days
- +5.7%
Measured over 30 trading days, to the Apr 21 close.
Traded Tue, Mar 7. Filed Thu, Mar 9, 11:47 AM ET, during the session. Returns use the Mar 9 close and the Apr 21 close. Not investment advice.